Embecta Corp. Common Stock (EMBC)
Embecta Corp. (EMBC) is a global diabetes care company focused on providing innovative medical products and solutions. Originally part of Becton, Dickinson and Company (BD), Embecta became an independent entity specializing in diabetes management, including insulin delivery devices and related products. The company aims to improve the quality of life for individuals with diabetes through its portfolio of trusted, high-quality healthcare solutions.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 15, 2025 | $0.15 | 2025-08-29 | 2025-08-29 |
| June 13, 2025 | $0.15 | 2025-05-28 | 2025-05-28 |
| March 14, 2025 | $0.15 | 2025-02-28 | 2025-02-28 |
| December 18, 2024 | $0.15 | 2024-12-06 | 2024-12-06 |
| September 13, 2024 | $0.15 | 2024-08-27 | 2024-08-27 |
Dividends Summary
- Embecta Corp. Common Stock has issued 13 dividend payments over the past 3 years
- The most recent dividend was paid 22 days ago, on September 15, 2025
- The highest dividend payed out to investors during this period was $0.15 per share
- The average dividend paid during this period was $0.15 per share.
Company News
Embecta Corp. announced participation in two upcoming investor conferences in September 2025, including a fireside session at the Wells Fargo Healthcare Conference and one-on-one investor meetings at the Morgan Stanley Global Healthcare Conference.
Becton Dickinson reported strong Q1 2025 results, with revenue and EPS beating estimates. However, the company lowered its fiscal year 2025 outlook and announced plans to separate its Biosciences and Diagnostic Solutions business by fiscal 2026.
CIXXF, JXN and EMBC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 15, 2024.